Use of sustained release dextroamphetamine for the treatment of stimulant use disorder in the setting of injectable opioid agonist treatment in Canada: a case report
For people with opioid use disorder who are not responding to oral opioid agonist treatment, evidence supports the effectiveness of injectable opioid agonist treatment with injectable hydromorphone (an opioid ...
Source: Harm Reduction Journal - Category: Drugs & Pharmacology Authors: Heather Palis, Scott MacDonald, Jennifer Jun and Eugenia Oviedo-Joekes Tags: Case report Source Type: research
More News: Canada Health | Drugs & Pharmacology